Hypertension & Cardiovascular Disease

Air Pollution, Global Warming Contribute to Kidney Disease

WASHINGTON, DC – Air pollution, water pollutants, and global warming are among the environmental factors contributing to the development of kidney disease, according to a presenter at Kidney Week 2019.

Kidney Week Speakers Offer Tips to Managing AKI in Pregnancy

WASHINGTON, DC – Acute kidney injury (AKI) is a rare but morbid complication of pregnancy, presenters said during Kidney Week 2019. Yet, cases are rising in developed countries, including the U.S., and understanding anatomic and physiologic changes is critical to understanding the diagnosis.

Plant-based Diets OK for People with Kidney Disease, Can Lead to Better Outcomes

WASHINGTON, DC – The effects of plant-based diets and phosphorous restriction on kidney disease were the subject of two talks presented at Kidney Week 2019.

Plant-based Diets OK for People with Kidney Disease, Can Lead to Better Outcomes

WASHINGTON, DC – The effects of plant-based diets and phosphorous restriction on kidney disease were the subject of two talks presented at Kidney Week 2019.

Caloric Restriction Could Help Obese Patients with Kidney Disease

WASHINGTON – Caloric restriction, whether through diet, bariatric surgery, or new sodium-glucose cotransporter-2 inhibitor (SGLT2) medications, could help improve measures of kidney disease in obese patients, according to a Kidney Week 2019 presentation.

ASN Communities – A Unique Educational Asset

Members from over 180 countries continue to regularly engage in ASN Communities.  In just three years, there have been almost 140,000 unique logins to the Communities.  The educational value of Communities was recognized in 2019 by the Kidney Week program committee when they accepted a submission about the international and educational value of Communities.  Members helping and supporting each other dealing with complex clinical cases, educational challenges, policy initiatives and more have created an online educational asset that

Interview with Dr. Michael Allon, editor-in-chief of Kidney360, on new ideas for the journal

allon-michael2_1.jpgKidney News Online (KNO) recently spoke with Michael Allon, MD, the inaugural Editor-in-Chief for the newest journal from the American Society of Nephrology, Kidney360. As the open access, online only journal began accepting manuscripts on October 1st, KNO wanted to learn more about the ideas behind the new journal.

 

Advancing Nephrology: Division Leaders Advise ASN

Asserting the value of nephrology

Physician productivity and compensation

Financial support of educational effort

Recruitment, retention, diversity and inclusion

Ensuring that Nephrology fellowship programs provide quality training in all aspects of kidney care

Dr. Reshma Kewalramani named incoming president and CEO of Vertex Pharmaceuticals, former member ASN KHI Board of Directors

Announced July 25, Dr. Reshma Kewalramani will be promoted to president and CEO of Vertex Pharmaceuticals. She is currently the chief medical officer for the company and was previously a practicing nephrologist who earned her medical doctorate at Boston University and trained at Bigham & Women’s Hospital.

Dr. Kewalramani will be the first woman to run a large biotechnology firm. Vortex’s share price “rose 360% and its sales doubled to $3 billion annually” under the previous CEO, largely due the company’s pharmaceuticals used to treat cystic fibrosis.

Pages